Janus Henderson Group PLC Beam Therapeutics Inc. Transaction History

Janus Henderson Group PLC

$194 Billion
Q2 2025

A detailed history of Janus Henderson Group PLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 39,501 shares of BEAM stock, worth $840,581. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,501

Previous 1,752,402 97.75%

Holding current value

$840,581

Previous $34.2 Million 98.04%

% of portfolio

0.0%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$14.54 - $20.24 $24.9 Million - $34.7 Million	-1,712,901 Reduced 97.75%	39,501 $671,000
Q1 2025 May 15, 2025	BUY	$19.53 - $34.09 $33.6 Million - $58.6 Million	1,719,901 Added 5291.84%	1,752,402 $34.2 Million
Q4 2024 Feb 14, 2025	SELL	$21.55 - $30.35 $96,975 - $136,575	-4,500 Reduced 12.16%	32,501 $806,000
Q2 2024 Aug 14, 2024	BUY	$21.22 - $32.66 $208,274 - $320,557	9,815 Added 36.1%	37,001 $866,000
Q1 2024 May 15, 2024	BUY	$23.46 - $45.07 $281 - $540	12 Added 0.04%	27,186 $898,000
Q4 2023 Feb 14, 2024	SELL	$17.69 - $30.76 $955 - $1,661	-54 Reduced 0.2%	27,174 $739,000
Q3 2023 Nov 14, 2023	BUY	$23.01 - $32.46 $1,748 - $2,466	76 Added 0.28%	27,228 $654,000
Q2 2023 Aug 14, 2023	SELL	$29.32 - $35.99 $2,257 - $2,771	-77 Reduced 0.28%	27,152 $866,000
Q1 2023 May 15, 2023	BUY	$30.15 - $48.79 $411,547 - $665,983	13,650 Added 100.52%	27,229 $833,000
Q4 2022 Feb 14, 2023	BUY	$36.73 - $51.6 $121,539 - $170,744	3,309 Added 32.22%	13,579 $531,000
Q3 2022 Nov 14, 2022	SELL	$39.79 - $70.31 $75,083 - $132,674	-1,887 Reduced 15.52%	10,270 $489,000
Q2 2022 Aug 15, 2022	BUY	$29.86 - $62.36 $173,307 - $361,937	5,804 Added 91.36%	12,157 $471,000
Q1 2022 May 16, 2022	BUY	$53.73 - $82.16 $341,346 - $521,962	6,353 New	6,353 $364,000

Others Institutions Holding BEAM

# of Institutions

247

Shares Held

95.7M

Call Options Held

666K

Put Options Held

1.99M

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.5B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Beam Therapeutics Inc. Transaction History